Kinarus Therapeutics Holding AG / Key word(s): Annual Results/Capital Increase Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination
17 April 2024: Publication of audited FY2023 Financial Statements of Kinarus Therapeutics Holding AG21 June 2024: Annual General MeetingKinarus Therapeutics Holding AG is a publicly listed therapeutic drug development company. The Kinarus Group consists of the SIX Swiss Exchange listed Kinarus Therapeutics Holding AG and the subsidiary Kinarus AG in Liquidation.
THIS DOCUMENT DOES NOT CONSTITUTE A PROSPECTUS WITHIN THE MEANING OF SWISS FINANCIAL SERVICES ACT , NOR A PROSPECTUS UNDER ANY OTHER APPLICABLE LAWS AND SHOULD NOT BE TREATED AS OFFERING MATERIALS OF ANY SORT AND IS FOR INFORMATION PURPOSES ONLY. THE INFORMATION CONTAINED HEREIN IS IN SUMMARY FORM AND MUST BE CONSIDERED IN CONJUCTION WITH AND SUBJECT TO THE PUBLICLY AVAILABLE INFORMATION OF KINARUS THERAPEUTICS HOLDING AG.
This document contains certain forward-looking statements. Other written materials, as well as other written and oral statements made to the public, may also contain forward-looking statements.
This document is not an offering circular or prospectus and is being furnished to you solely for your information and may not be reproduced, redistributed or made available in whole or in part to any other person for any purpose, without the prior consent of Kinarus Therapeutics Holding AG. This document is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgement.
Großer Insider-Report 2024 von Dr. Dennis RiedlWenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.Hier klicken
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ADC Therapeutics SA: ADC Therapeutics Gewährt Zuschüsse an neue Mitarbeiter im Rahmen des AnreizplanLAUSANNE, Schweiz, April 02, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (das «Unternehmen») (NYSE: ADCT) gab heute bekannt, dass das Unternehmen sechs neuen Mitarbeitern am 1. April 2024 Optionen auf
続きを読む »
PTA-Adhoc: medondo holding ag: Die medondo holding AG meldet die Platzierung einer WandelschuldverschreibungDJ PTA-Adhoc: medondo holding ag: Die medondo holding AG meldet die Platzierung einer Wandelschuldverschreibung Veröffentlichung von Insiderinformationen gemäß Artikel 17 MAR München (pta/30.03.2024/18:05)
続きを読む »
Global Ports Holding PLC: Holding(s) in CompanyDJ Holding(s) in Company Global Ports Holding PLC (GPH) Holding(s) in Company 28-March-2024 / 18:52 GMT/BST=----------------------------------------------------------------------------------------------------------------------
続きを読む »
PTA-Adhoc: HÖVELRAT Holding AG: HÖVELRAT HOLDING AG ERWIRBT TAM AGDJ PTA-Adhoc: HÖVELRAT Holding AG: HÖVELRAT HOLDING AG ERWIRBT TAM AG Veröffentlichung von Insiderinformationen gemäß Artikel 17 MAR Hamburg (pta/08.04.2024/15:15) - Die HÖVELRAT Holding AG (WKN
続きを読む »
?Press Release?Sinopec FY2023 Annual ResultsDJ ?Press Release?Sinopec FY2023 Annual Results EQS Newswire / 24/03/2024 / 19:25 UTC+8 Press release (For immediate release) Sinopec Achieved Solid 2023 Operating Results Focus on
続きを読む »
?Press Release?Sinopec FY2023 Annual Results -2-DJ ?Press Release?Sinopec FY2023 Annual Results EQS Newswire / 24/03/2024 / 19:25 UTC+8 Press release (For immediate release) Sinopec Achieved Solid 2023 Operating Results Focus on
続きを読む »